Program Overview:
The joint providers of Medical Education Resources (MER), the Chronic Liver Disease Foundation (CLDF), Gastroenterology and Hepatology Advanced Practice Providers (GHAPP), and the Global NASH Council (GNC) present MASLD: Current Risk Stratification and Treatment. The program will focus on the latest data regarding MASH disease burden, noninvasive testing (NITs), risk stratification algorithms, treatment modalities, and management guidelines.
Target Audience:
This activity has been designed to meet the educational needs of gastroenterologists, hepatologists, nurse practitioners (NPs), and physician
assistants/associates (PAs) who are currently managing and treating patients with metabolic dysfunction-associated steatohepatitis (MASH).
Educational Objectives:
-
Evaluate the role of risk stratification in MASLD/MASH, including its prognostic value and role in guiding treatment decisions.
-
Integrate noninvasive tests (NITs) into clinical pathways for the identification and categorization of liver fibrosis.
-
Utilize NITs to monitor treatment response and assess long-term clinical outcomes.
Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources, the Chronic Liver Disease Foundation, Gastroenterology and Hepatology Advanced Practice Providers, and the Global NASH Council. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Associate Credit:
Medical Education Resources has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.
Physician Credit:
Medical Education Resources designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Credit:
Medical Education Resources designates this live activity for a maximum of 1.00 ANCC nursing contact hour. Nurses will be awarded contact hours upon successful completion of the activity.
This activity is designated for 0.3 ANCC pharmacotherapeutic contact hour. Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 1.00 contact hour.
Disclosure of Relevant Financial Relationships:
Medical Education Resources (MER) ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies all financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.
MER, the Chronic Liver Disease Foundation, Gastroenterology and Hepatology Advanced Practice Providers, and the Global NASH Council planners have no relevant financial relationships to disclose.
Disclaimer:
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, the Chronic Liver Disease Foundation, Gastroenterology and Hepatology Advanced Practice Providers, and the Global NASH Council, and/or Siemens Healthcare Diagnostics Inc. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
Fee Information: There is no fee for this educational activity.
Jointly provided by Medical Education Resources, the Chronic Liver Disease Foundation, Gastroenterology and Hepatology Advanced Practice Providers, and the Global NASH Council.
Supported by an educational grant from Siemens Healthcare Diagnostics Inc.
